FORENSIC TOXICOLOGY - Bio Medical Forensics

Schwope, David M. MS*, National Institute of Heath,
NIDA, 251 Bayview Boulevard, Suite 200, Room 05A721,
Baltimore, MD 21224; Karl B. Scheidweiler, PhD,
National Institute of Heath, NIDA/IRP, 251 Bayview
Boulevard, Suite 200, Room 05A721, Baltimore, MD
21224; and Marilyn A. Huestis, PhD, Chemistry & Drug
Metabolism, Intramural Research, National Institute of
Heath, NIDA, 251 Bayview Boulevard, Room 05A721,
Baltimore, MD 21224
Scott, Karen S. PhD*, Department of Forensic Medicine
and Science, University of Glasgow, University Place,
Glasgow, G12 8QQ, UNITED KINGDOM
Scurlock, Rodger D. PhD*, Greg B. Ohlson, MS, and
David K. Worthen, BA, Arizona Department of Public
Safety, Central Regional Crime Lab, 2102 W. Encanto
Blvd, Phoenix, AZ 85005
Sebring, Robert J. BS*, New Mexico Department of Health
- SLD, Forensic Toxicology Bureau, PO Box 4700,
Albuquerque, NM 87196- 4700; Nancy G. Drez, BS,
Scientific Laboratory Division, PO Box 4700, 700 Camino
De Salud, Northeast, Albuquerque, NM 87196; and Rong-
Jen Hwang, PhD, New Mexico Department of Health -
SLD, Forensic Toxicology Bureau, PO Box 4700,
Albuquerque, NM 87196-4700
Seither, Joshua Z. BS*, 3645 Spring Valley Road, Akron,
OH 44333; and H.M. Kingston, PhD, and Timothy
Fahrenholz, BS, Duquesne University, 700 Forbes Avenue,
Pittsburgh, PA 15219
Selavka, Carl M. PhD*, Massachusetts State Police, 59
Horse Pond Road, Sudbury, MA 01776; and Donald J.
Kippenberger, PhD, U.S. Army Medical Command
(USAMEDCOM), Toxicology Specialty Command, Ft. Sam
Houston, TX 78160
Sellers, Kristi BS* and Rebecca Wittrig, Restek
Corporation, 110 Benner Circle, Bellefonte, PA 16823;
and Andre Schreiber, PhD, Applied Biosystems, 71 Four
Valley Drive, Concord, Ontario, L4K 4V8 CANADA
Shakleya, Diaa M. PhD*, National Institute on Drug
Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224;
Riet Dams, PhD, Laboratory of Toxicology, Ghent
University, Harelbekestraat 72, B-9000, BELGIUM; Robin
Choo, PhD, University of Pittsburgh, Titusville, PA;
Hendree Jones, PhD, 4 Center for Addiction and
Pregnancy, JHBMC, Baltimore, MD 21224; and Marilyn
A. Huestis, PhD, Chemistry & Drug Metabolism,
Intramural Research, National Institute on Drug Abuse,
National Institutes of Health, 5500 Nathan Shock Drive,
Baltimore, MD 21224
Index 106
Direct LC/MS/MS Quantification of Plasma
Cannabinoids and Their Glucuronides
Validation of a Method for the Determination
of Opiates and Methadone in Hair
The Detection of THC and THCA in Whole
Blood Using Two-Dimensional Gas
Chromatography and EI-MS
Measurement Uncertainty of GC Method in
Determining Ethanol Concentration of In-
House Prepared Aqueous Standards for use
with Evidentiary Breath Test Instruments
An Application of Speciated Isotope Dilution
Mass Spectrometry (SIDMS) for
Simultaneous Drug Quantitation of Gamma-
Hydroxybutyric Acid (GHB) and Gamma-
Butyrolactone (GBL) in Urine and Blood
Matrices
How HHS is Applying Recommendations
From the Hair Testing Working Group
22
79
166
2
10
191
Analyzing Cannabiniods by HPLC/MS/MS 104
Simultaneous LC-MS/MS Quantification of
Opiate, Cocaine, and Metabolites in Urine of
Pregnant Substance-Abuse Treatment
Participants
96